Multimerization of Adenovirus Serotype 3 Fiber Knob Domains Is Required for Efficient Binding of Virus to Desmoglein 2 and Subsequent Opening of Epithelial Junctions

Advances in Platinum Chemotherapeutics

(2010) Benjamin W. Harper et al.   CHEMISTRY-A EUROPEAN JOURNAL

Conditionally Replicating Adenovirus Expressing TIMP2 for Ovarian Cancer Therapy

(2010) S. W. Yang et al.   CLINICAL CANCER RESEARCH

Macropinocytotic Uptake and Infection of Human Epithelial Cells with Species B2 Adenovirus Type 35

(2010) S. Kalin et al.   JOURNAL OF VIROLOGY

Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF

(2010) Anniina Koski et al.   MOLECULAR THERAPY

Desmoglein 2 is a receptor for adenovirus serotypes 3, 7, 11 and 14

(2010) Hongjie Wang et al.   NATURE MEDICINE

Epithelial Phenotype Confers Resistance of Ovarian Cancer Cells to Oncolytic Adenoviruses

(2009) R. Strauss et al.   CANCER RESEARCH

Enhancing Cancer Vaccine Efficacy via Modulation of the Tumor Microenvironment

(2009) M. L. Disis   CLINICAL CANCER RESEARCH

Adenovirus 5–Fiber 35 Chimeric Vector Mediates Efficient Apical Correction of the Cystic Fibrosis Transmembrane Conductance Regulator Defect in Cystic Fibrosis Primary Airway Epithelia

(2009) Ophélia Granio et al.   HUMAN GENE THERAPY

Adenovirus receptors: implications for tropism, treatment and targeting

(2009) Niklas Arnberg   REVIEWS IN MEDICAL VIROLOGY

Targeting YB-1 in HER-2 Overexpressing Breast Cancer Cells Induces Apoptosis via the mTOR/STAT3 Pathway and Suppresses Tumor Growth in Mice

(2008) Cathy Lee et al.   CANCER RESEARCH

Generation and Characterization of Monoclonal Antibodies Against the Proregion of Human Desmoglein-2

(2008) Sarah A. Keim et al.   HYBRIDOMA

Mechanisms of Disease: epithelial–mesenchymal transition—does cellular plasticity fuel neoplastic progression?

(2008) Eva A Turley et al.   Nature clinical practice. Oncology

Role of Cellular Heparan Sulfate Proteoglycans in Infection of Human Adenovirus Serotype 3 and 35

(2008) Sebastian Tuve et al.   PLoS Pathogens